| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Teichmann Sarah A. | Director | C/O 10X GENOMICS, INC., 6230 STONERIDGE MALL ROAD, PLEASANTON | /s/ Randy Wu, as Attorney-in-Fact for Sarah A. Teichmann | 27 Feb 2026 | 0002030916 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TXG | Class A Common Stock | Sale | $147,108 | -7,579 | -22% | $19.41 | 26,780 | 25 Feb 2026 | Direct | F1 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 26, 2025. |
Exhibit 24.1 - Power of Attorney